Epigenetic regulation of HIV latency

Current Opinion in HIV and AIDS

Volumn 6, Issue 1, 2011, Pages 19-24

  Hakre, Shweta ^a,b   Chavez, Leonard ^a,b   Shirakawa, Kotaro ^a,b   Verdin, Eric ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin; Epigenetics; HIV latency; Nucleosome; Transcription; Virus

Indexed keywords

CIS ACTING ELEMENT; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; VIRUS DNA;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENETICS; GENE CONTROL; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS LATENCY; VIRUS REACTIVATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENICITY; REVIEW; VIROLOGY;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS LATENCY;

EID: 79954441587     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283412384     Document Type: Article

References (52)

1. Pomerantz RJ, Horn DL. Twenty years of therapy for HIV-1 infection. Nat Med 2003; 9:867-873. (Pubitemid 36889928)
2. Pomerantz RJ. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin Infect Dis 2002; 34:91-97. (Pubitemid 33152672)
3. Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 2008; 122:22-28. (Pubitemid 351899083)
4. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, et al. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 2009; 7:798-812.
5. Lassen K, Han Y, Zhou Y, et al. The multifactorial nature of HIV-1 latency. Trends Mol Med 2004; 10:525-531. (Pubitemid 39433821)
6. Colin L, Van Lint C. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 2009; 6:111.
7. El Kharroubi A, Piras G, Zensen R, et al. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 1998; 18:2535-2544. (Pubitemid 28183423)
8. Legube G, Trouche D. Identification of a larger form of the histone acetyl transferase Tip60. Gene 2003; 310:161-168. (Pubitemid 36703310)
9. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002; 108:475-487. (Pubitemid 34260873)
10. He G, Margolis DM. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 2002; 22:2965-2973. (Pubitemid 34437455)
11. Ansari KI, Mishra BP, Mandal SS. MLL histone methylases in gene expression, hormone signaling and cell cycle. Front Biosci 2009; 14:3483-3495.
12. Kauder SE, Bosque A, Lindqvist A, et al. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 2009; 5:e1000495.
13. Blazkova J, Trejbalova K, Gondois-Rey F, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog 2009; 5:e1000554.
14. Zhang Y, Ng HH, Erdjument-Bromage H, et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999; 13:1924-1935. (Pubitemid 29407360)
15. Bird AP, Wolffe AP. Methylation-induced repression: belts, braces, and chromatin. Cell 1999; 99:451-454. (Pubitemid 129746827)
16. Marban C, Suzanne S, Dequiedt F, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 2007; 26:412-423. (Pubitemid 46160942)
17. Imai K, Togami H, Okamoto T. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 2010; 285:16538-16545.
18. Du Chene I, Basyuk E, Lin YL, et al. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and postintegration latency. EMBO J 2007; 26:424-435. (Pubitemid 46160943)
19. Lusic M, Marcello A, Cereseto A, et al. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 2003; 22:6550-6561. (Pubitemid 38009602)
20. Zhou M, Deng L, Lacoste V, et al. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. J Virol 2004; 78:13522-13533. (Pubitemid 39612752)
21. Guccione E, Bassi C, Casadio F, et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007; 449:933-937. (Pubitemid 47598605)
22. Brown MA, Sims RJ 3rd, Gottlieb PD, et al. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol Cancer 2006; 5:26.
23. Mateescu B, Bourachot B, Rachez C, et al. Regulation of an inducible promoter by an HP1beta-HP1gamma switch. EMBO Rep 2008; 9:267-272. (Pubitemid 351330992)
24. Verdin E. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol 1991; 65:6790-6799.
25. Verdin E, Paras P Jr, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 1993; 12:3249-3259. (Pubitemid 23232756)
26. Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996; 5:245-253.
27. Van Lint C, Emiliani S, Ott M, et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 1996; 15:1112-1120. (Pubitemid 26077840)
28. Coull JJ, Romerio F, Sun JM, et al. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 2000; 74:6790-6799. (Pubitemid 30470662)
29. Williams SA, Chen LF, Kwon H, et al. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 2006; 25:139-149. (Pubitemid 43077303)
30. Tyagi M, Karn J. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J 2007; 26:4985-4995. (Pubitemid 350261291)
31. Marban C, Redel L, Suzanne S, et al. COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res 2005; 33:2318-2331. (Pubitemid 41439899)
32. Keedy KS, Archin NM, Gates AT, et al. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 2009; 83:4749-4756.
33. Imai K, Okamoto T. Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 2006; 281:12495-12505. (Pubitemid 43855336)
34. Jiang G, Espeseth A, Hazuda DJ, et al. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 2007; 81:10914-10923. (Pubitemid 47536066)
35. Marsili G, Remoli AL, Sgarbanti M, et al. Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann N Y Acad Sci 2004; 1030:636-643. (Pubitemid 40378963)
36. Benkirane M, Chun RF, Xiao H, et al. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 1998; 273:24898-24905. (Pubitemid 28454997)
37. Ott M, Schnolzer M, Garnica J, et al. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 1999; 9:1489-1492. (Pubitemid 30023485)
38. Cheutin T, McNairn AJ, Jenuwein T, et al. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 2003; 299:721-725. (Pubitemid 36159490)
39. Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 2004; 5:296-304. (Pubitemid 38480610)
40. + T cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 2010; 84:6425-6437.
41. Emiliani S, Fischle W, Ott M, et al. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J Virol 1998; 72:1666-1670. (Pubitemid 28116960)
42. Pearson R, Kim YK, Hokello J, et al. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 2008; 82:12291-12303.
43. + T cells. Blood 2009; 113:58-65.
44. Agbottah E, Deng L, Dannenberg LO, et al. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription. Retrovirology 2006; 3:48.
45. Treand C, du Chene I, Bres V, et al. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J 2006; 25:1690-1699.
46. Mahmoudi T, Parra M, Vries RG, et al. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 2006; 281:19960-19968. (Pubitemid 44065769)
47. Easley R, Carpio L, Dannenberg L, et al. Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription. Virology 2010; 405:322-333.
48. Qumsiyeh MB. Structure and function of the nucleus: anatomy and physiology of chromatin. Cell Mol Life Sci 1999; 55:1129-1140. (Pubitemid 29361078)
49. Ciuffi A, Llano M, Poeschla E, et al. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 2005; 11:1287-1289. (Pubitemid 41752906)
50. Lewinski MK, Bisgrove D, Shinn P, et al. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 2005; 79:6610-6619. (Pubitemid 40677292)
51. Wade PA. Methyl CpG-binding proteins and transcriptional repression. Bioessays 2001; 23:1131-1137.
52. Craig JM. Heterochromatin: many flavours, common themes. Bioessays 2005; 27:1728.